MS Research Through the Patient Lens: Key Takeaways from Patient Community Day 2025
Patient Community Day 2025 set a new attendance record, highlighting the growing desire among people living with MS to connect with experts leading the charge in understanding the disease and advancin...
15 Loka 202521min
Can We Repair Myelin in Multiple Sclerosis? Results from the CCMR-Two Trial
Can damaged myelin be repaired in people living with multiple sclerosis? Results from the CCMR-Two clinical trial presented at ECTRIMS 2025 offered promising new evidence for remyelination using a com...
2 Loka 202525min
What's Next for MS Treatment? Key Takeaways from ECTRIMS 2025
What were the biggest developments in multiple sclerosis treatment at ECTRIMS 2025? As the 41st Congress came to a close in Barcelona, attention turned to new clinical trial results and what they coul...
26 Syys 202516min
New MS Research and Treatment Advances: Highlights from ECTRIMS 2025 | Day Two
What were some of the most important new developments in multiple sclerosis research and treatment at ECTRIMS 2025? Dr. Barry Singer, Director and Founder of The MS Center for Innovations in Care, joi...
25 Syys 202520min
Day 1 Highlights of ECTRIMS 2025
The 41st Congress of ECTRIMS opened in Barcelona with Professor Maria Pia Amato of the University of Florence delivering the ECTRIMS Lecture. In this conversation with host Brett Drummond, she highlig...
24 Syys 202523min
Pre-Day Highlights of ECTRIMS 2025
Direct from Barcelona, listen to Alvaro Cobo Calvo from the Multiple Sclerosis Center of Catalonia (Cemcat) and host Brett Drummond discuss the highlights of ECTRIMS 2025 Pre-Day, which is focused on ...
23 Syys 202517min
2024 Revisions of the McDonald Diagnostic Criteria: What Neurologists Need to Know
The 2024 Revisions of the McDonald Diagnostic Criteria for MS have been published in The Lancet Neurology. What do these changes mean for clinical practice? In this episode, we are joined by two autho...
19 Syys 202520min
Genetics and MS: Recent Discoveries and Future Directions
Genetics not only influence the risk of developing multiple sclerosis (MS), but also affect how the disease progresses and how patients respond to different treatments. Professor Philip De Jager, Chie...
8 Syys 202527min
